程序性死亡受体-1/程序性死亡受体-配体1抑制剂联合不同方案抗癌治疗的相关不良事件发生率及其严重程度分级

Journal of Clinical Medicine in Practice ›› 2025, Vol. 29 ›› Issue (02) : 19-23.

Author information +
History +

CLC number

R730.5

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations

Comments

Accesses

Citation

Detail
Sections
Recommended
Copyright © Journal of Clinical Medicine in Practice, All Rights Reserved.
Powered by Beijing Magtech Co. Ltd.

/

〈 〉